US Stock MarketDetailed Quotes

INO Inovio Pharmaceuticals

Watchlist
  • 8.7100
  • +0.1200+1.40%
Close Aug 8 16:00 ET
  • 8.3500
  • -0.3600-4.13%
Post 17:46 ET
225.68MMarket Cap-1580P/E (TTM)

Inovio Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Inovio Pharmaceuticals Earnings Date

Currency: USD

Period

Q2 FY2024 Estimates

Aug 8, 2024

Revenue(YoY)

121.50K

-46.23%
EPS(YoY)

-1.10

+29.38%
Analyst Rating

Buy

Jul 31, 2024

Inovio Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 121.670K--
Aug 8, 20242024/Q2-- / 121.500K--
May 13, 20242024/Q10.000 / 150.800K--
Mar 6, 20242023/Q4102.650K / 344.120K--
Nov 9, 20232023/Q3388.450K / 262.500K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 121.670K--
Aug 8, 20242024/Q2-- / 121.500K--
May 13, 20242024/Q10.000 / 150.800K--
Mar 6, 20242023/Q4102.650K / 344.120K--
Nov 9, 20232023/Q3388.450K / 262.500K--

Unlock Free Earnings Estimates

Inovio Pharmaceuticals Earnings Reports

  • Inovio Pharmaceuticals | 10-Q: Quarterly report

    16:14 ET

  • Inovio Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 13 16:05 ET

  • Inovio Pharmaceuticals | 10-K: FY2023 Annual Report

    Mar 6 16:06 ET

  • Inovio Pharmaceuticals: Q3 2023 Earnings Report

    Nov 9, 2023 16:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 31, 2024

    Buy

    • Buy

      66.67%

    • Hold

      33.33%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg